Cohen Y - Search Results

1

Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patients.

Isaacs C, Cavalli LR, Cohen Y, Pennanen M, Shankar LK, Freedman M, Singh B, Liu M, Gallagher A, Rone JD, Dickson RB, Sidransky D, Haddad BR. Isaacs C, et al. Among authors: cohen y. Breast Cancer Res Treat. 2004 Mar;84(2):99-105. doi: 10.1023/B:BREA.0000018406.03679.2e. Breast Cancer Res Treat. 2004. PMID: 14999140

2

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.

Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH. Cohen Y, et al. Clin Cancer Res. 2004 Apr 15;10(8):2761-5. doi: 10.1158/1078-0432.ccr-03-0273. Clin Cancer Res. 2004. PMID: 15102681

3

Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations.

Mambo E, Gao X, Cohen Y, Guo Z, Talalay P, Sidransky D. Mambo E, et al. Among authors: cohen y. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1838-43. doi: 10.1073/pnas.0437910100. Epub 2003 Feb 10. Proc Natl Acad Sci U S A. 2003. PMID: 12578990 Free PMC article.

4

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.

Begum S, Rosenbaum E, Henrique R, Cohen Y, Sidransky D, Westra WH. Begum S, et al. Among authors: cohen y. Mod Pathol. 2004 Nov;17(11):1359-63. doi: 10.1038/modpathol.3800198. Mod Pathol. 2004. PMID: 15195111 Free article.

5

Lack of BRAF mutation in primary uveal melanoma.

Cohen Y, Goldenberg-Cohen N, Parrella P, Chowers I, Merbs SL, Pe'er J, Sidransky D. Cohen Y, et al. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2876-8. doi: 10.1167/iovs.02-1329. Invest Ophthalmol Vis Sci. 2003. PMID: 12824225

6

T1799A BRAF mutations in conjunctival melanocytic lesions.

Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D, Pe'er J, Sidransky D. Goldenberg-Cohen N, et al. Among authors: cohen y. Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3027-30. doi: 10.1167/iovs.04-1449. Invest Ophthalmol Vis Sci. 2005. PMID: 16123397

7

Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.

Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D. Rosenbaum E, et al. Among authors: cohen y. Clin Cancer Res. 2005 Dec 1;11(23):8321-5. doi: 10.1158/1078-0432.CCR-05-1183. Clin Cancer Res. 2005. PMID: 16322291

8

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. Cohen Y, et al. Clin Cancer Res. 2003 Aug 1;9(8):2981-4. Clin Cancer Res. 2003. PMID: 12912945

9

Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis.

Xing M, Cohen Y, Mambo E, Tallini G, Udelsman R, Ladenson PW, Sidransky D. Xing M, et al. Among authors: cohen y. Cancer Res. 2004 Mar 1;64(5):1664-8. doi: 10.1158/0008-5472.can-03-3242. Cancer Res. 2004. PMID: 14996725

10

The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.

Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Chakravarti A. Maitra A, et al. Among authors: cohen y. Genome Res. 2004 May;14(5):812-9. doi: 10.1101/gr.2228504. Genome Res. 2004. PMID: 15123581 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,942 results

Search Page

Filters